Eaton Vance Management’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.23M | Hold |
3,779
| – | – | ﹤0.01% | 1182 |
|
|
2022
Q2 | $998K | Hold |
3,779
| – | – | ﹤0.01% | 1254 |
|
|
2022
Q1 | $1.14M | Hold |
3,779
| – | – | ﹤0.01% | 1335 |
|
|
2021
Q4 | $1.33M | Hold |
3,779
| – | – | ﹤0.01% | 1119 |
|
|
2021
Q3 | $966K | Hold |
3,779
| – | – | ﹤0.01% | 1097 |
|
|
2021
Q2 | $2.52M | Hold |
3,779
| – | – | ﹤0.01% | 958 |
|
|
2021
Q1 | $3.28M | Hold |
3,779
| – | – | ﹤0.01% | 851 |
|
|
2020
Q4 | $3.5M | Hold |
3,779
| – | – | 0.01% | 797 |
|
|
2020
Q3 | $3.89M | Hold |
3,779
| – | – | 0.01% | 688 |
|
|
2020
Q2 | $3.83M | Sell |
3,779
-3
| -0.1% | -$3.04K | 0.01% | 660 |
|
|
2020
Q1 | $3.29M | Buy |
3,782
+3
| +0.1% | +$2.61K | 0.01% | 642 |
|
|
2019
Q4 | $4.05M | Hold |
3,779
| – | – | 0.01% | 663 |
|
|
2019
Q3 | $3.49M | Buy |
3,779
+1,699
| +82% | +$1.57M | 0.01% | 677 |
|
|
2019
Q2 | $2.35M | Hold |
2,080
| – | – | 0.01% | 772 |
|
|
2019
Q1 | $2.83M | Buy |
2,080
+360
| +21% | +$489K | 0.01% | 688 |
|
|
2018
Q4 | $1.99M | Hold |
1,720
| – | – | 0.01% | 724 |
|
|
2018
Q3 | $2.61M | Hold |
1,720
| – | – | 0.01% | 689 |
|
|
2018
Q2 | $2.69M | Sell |
1,720
-1,720
| -50% | -$2.69M | 0.01% | 668 |
|
|
2018
Q1 | $3.97M | Buy |
3,440
+1,720
| +100% | +$1.99M | ﹤0.01% | 711 |
|
|
2017
Q4 | $2.04M | Hold |
1,720
| – | – | ﹤0.01% | 706 |
|
|
2017
Q3 | $2.31M | Hold |
1,720
| – | – | 0.01% | 661 |
|
|
2017
Q2 | $1.39M | Buy |
1,720
+800
| +87% | +$646K | ﹤0.01% | 747 |
|
|
2017
Q1 | $567K | Buy |
+920
| New | +$567K | ﹤0.01% | 878 |
|